Skip Nav Destination

Interleukin-1 in cerebrospinal fluid for evaluating the neurological outcome in traumatic brain injury

Biosci Rep (2019) 39 (4): BSR20181966.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches

I.A. Clark
B. Vissel

Journal of Alzheimer's Disease (2021) 79 (3): 931.

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE
Correspondence address – Kemp House, 152-160 City Road, London EC1V 2NX

Portland Press Tel
+44 (0)20 3880 2795

Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Interleukin-1 in cerebrospinal fluid for evaluating the neurological outcome in traumatic brain injury

CONNECT

EXPLORE

Interleukin-1 in cerebrospinal fluid for evaluating the neurological outcome in traumatic brain injury

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only